Qnexa improves quality of life in the obese
Vivus has presented additional data that demonstrates that its anti-obesity treatment candidate Qnexa significantly improves quality of life in obese patients, during the American Association of Diabetes Educators meeting in Las Vegas, Nevada.
Federal health officials shot down approval for the new weight loss drug Qnexa Thursday.